PCIA
ZOM

Prime Capital Investment Advisors’s Zomedica Corp. ZOM Stock Holding History

Prime Capital Investment Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39,088
Closed -$2.27K – 1134
2025
Q1 		$2.27K Hold
39,088
– – ﹤0.01% 1056
2024
Q4 		$4.69K Hold
39,088
– – ﹤0.01% 926
2024
Q3 		$5.36K Hold
39,088
– – ﹤0.01% 918
2024
Q2 		$5.71K Hold
39,088
– – ﹤0.01% 924
2024
Q1 		$5.7K Buy
39,088
+21,866
+127% +$3.06K ﹤0.01% 1005
2023
Q4 		$3.45K Sell
17,222
-5,000
-23% -$879 ﹤0.01% 957
2023
Q3 		$3.71K Buy
+22,222
New +$4.32K ﹤0.01% 753

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
RF
Rossby Financial Melbourne, Florida $547M AUM 30.65% 1-Year Est. Return

Prime Capital Investment Advisors's ZOM Position: Q2 2025 in Review

Prime Capital Investment Advisors sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 39,088 shares — an estimated $2.27K sold.

Prime Capital Investment Advisors first reported a position in ZOM in Q3 2023 and held it in 7 quarters. The position peaked at $5.71K in Q2 2024. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

  • Prime Capital Investment Advisors reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 39,088 Zomedica Corp. shares in Q2 2025, an estimated $2.27K.
  • Prime Capital Investment Advisors first reported a position in Zomedica Corp. in Q3 2023 and held it in 7 quarters.
  • Prime Capital Investment Advisors's Zomedica Corp. position peaked at $5.71K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.